In terms of glioma patient prognosis, higher levels of ZDHHC4 represented shorter overall survival and disease-free survival, which were obtained from TCGA, Chinese Glioma Genome Atlas (CGGA), and REMBRANDT (Fig. 6C, D; Supplementary Fig. 9C D). The gene discussed is ZDHHC4; the disease is central nervous system cancer.